Agili-C

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

MAH:

Cartiheal (2009) Ltd.

class:

בית חולים

manufactured_by:

Cartiheal (2009) Ltd.

therapeutic_group:

רופא

therapeutic_indication:

Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. It is indicated for cartilage and/or bone repair. The implant serves as a scaffold for cellular and matrix ingrowth. The Agili-C implant is expected to biodegrade within 6 – 12 months.

leaflet_short:

Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. It is indicated for cartilage and/or bone repair. The implant serves as a scaffold for cellular and matrix ingrowth. The Agili-C implant is expected to biodegrade within 6 – 12 months.